Skip to content

Epidemiological Characteristics and Prognosis Factors of Cancer Patients Admitted at French Emergency Departments

Epidemiological Characteristics and Prognosis Factors of Cancer Patients Admitted at French Emergency Departments

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03393260
Acronym
EPICANCER
Enrollment
1380
Registered
2018-01-08
Start date
2018-02-06
Completion date
2019-10-31
Last updated
2020-01-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Patients, Emergencies

Keywords

cancer, emergency departments (ED)

Brief summary

Patients with cancer or hematological malignancy are susceptible to present acute complications linked to their disease or to their specific treatments (dyspnea, sepsis, coma, hemorrhagic syndrome). Emergency physicians are in first line when these complications arise and have to face with some complex situations in which informations about patient malignancy or prognosis may be lacking. Nowadays, there is very few epidemiological data published concerning how cancer patient use Emergency Departments (EDs) and cancer patient care delivery in the EDs. Thus, an observational multicenter prospective cross-sectional study is conducted to study the prevalence of cancer patients admitted to French EDs, and to describe the different reasons for cancer patients to seek care in EDs with their prevalence and underscore those linked to cancer or treatment complication

Interventions

None listed

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult patients (age \>=18 years) * with active malignancy or a history of cancer in remission within the last 5 years * being attended in one of the 400 French emergency centers participating in the study during the 3-day study period

Exclusion criteria

* opposition to participate

Design outcomes

Primary

MeasureTime frame
Reasons for cancer patients to seek care in EDs1 day

Secondary

MeasureTime frame
cancer location1 day
hospitalisation rate1 day
intensive care unit (ICU) admission7 days
ICU mortality7 days

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026